DGAP-Adhoc: HAEMATO AG: appropriation of profits

DGAP-Ad-hoc: HAEMATO AG / Key word(s): Dividend
HAEMATO AG: appropriation of profits

21-Apr-2020 / 18:38 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad-hoc of HAEMATO AG:

The Supervisory Board of HAEMATO AG (ISIN: DE0006190705) approved today's proposal for the appropriation of profits by the Management Board in today's balance sheet meeting. Accordingly, the management of the Annual General Meeting on July 8, 2020 will propose that the retained earnings for the 2019 financial year be carried forward to new account.

About HAEMATO:
HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the growth markets of high-priced specialty pharmaceuticals. The focus is on therapies for cancer, HIV and other chronic diseases.

HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange. Key figures of the HAEMATO AG share:
Subscribed capital: EUR 22,867,154
Listed class of shares: Bearer ordinary shares
ISIN: DE0006190705
WKN: 619070
Stock exchange code: HAE

Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.ag

21-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English Company: HAEMATO AG Lilienthalstraße 5c 12529 Schönefeld Germany Phone: +49 (0)30 897 30 86 70 Fax: +49 (0)30 897 30 86 79 E-mail: ir@haemato.ag Internet: www.haemato.ag ISIN: DE0006190705 WKN: 619070 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange EQS News ID: 1026705
End of Announcement DGAP News Service

1026705 21-Apr-2020 CET/CEST